References
- AlbaneseAThe clinical expression of primary dystoniaJ Neurol2003250101145115114586593
- AlbaneseAJankovicJHyperkinetic Movement Disorders Differential diagnosis and treatmentLondon, UKWiley-Blackwell2011
- Fernandez-AlvarezEDystonia. The paediatric perspectiveEur J Neurol201017Suppl 1465120590808
- SchneiderSASecondary dystonia: clinical clues and syndromic associationsAlbaneseAJankovicJHyperkinetic Movement Disorders Differential diagnosis and treatmentLondon, UKWiley-Blackwell2011212226
- Fernandez-AlvarezEPrevalence of paediatric movement disordersFernandez-AlvarezETolosaEArzimanogolouAPediatric Movement DisordersMontrouge, FranceJohn Libbey Eurotext2005118
- WenningGKKiechlSSeppiKPrevalence of movement disorders in men and women aged 50–89 years (Bruneck study cohort): A population-based studyLancet Neurol200541281582016297839
- DefazioGThe epidemiology of primary dystonia: Current evidence and perspectivesEur J Neurol201017Suppl 1914
- ValenteEMAlbaneseAAdvances in the genetics of primary torsion dystoniaF1000 Biol Rep201024120948792
- BressmanSBde LeonDKramerPLDystonia in Ashkenazi Jews: Clinical characterization of a founder mutationAnn Neurol19943657717777979224
- ValenteEMWarnerTTJarmanPRThe role of DYT1 in primary torsion dystonia in EuropeBrain1998121Pt 12233523399874484
- ZorziGGaravagliaBInvernizziFFrequency of DYT1 mutation in early onset primary dystonia in Italian patientsMov Disord200217240740811921134
- RischNde LeonDOzeliusLGenetic analysis of idiopathic torsion dystonia in ashkenazi jews and their recent descent from a small founder populationNat Genet1995921521597719342
- FredericMLucarzEMoninoCFirst determination of the incidence of the unique TOR1A gene mutation, c.907delGAG, in a mediterranean populationMov Disord200722688488817290457
- BressmanSBSabattiCRaymondDThe DYT1 phenotype and guidelines for diagnostic testingNeurology20005491746175210802779
- GattoEMPardalMMMicheliFEUnusual phenotypic expression of the DYT1 mutationParkinsonism Relat Disord20039527727912781594
- OpalPTintnerRJankovicJIntrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic stormMov Disord200217233934511921121
- HansonPIWhiteheartSWAAA+ proteins: Have engine, will workNat Rev Mol Cell Biol20056751952916072036
- GoodchildREDauerWTMislocalization to the nuclear envelope: An effect of the dystonia-causing torsinA mutationProc Natl Acad Sci U S A2004101384785214711988
- HewettJWZengJNilandBPBraggDCBreakefieldXODystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamicsNeurobiol Dis20062219811116361107
- GilesLMChenJLiLChinLSDystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelopeHum Mol Genet200817172712272218552369
- GranataAKooSJHauckeVSchiavoGWarnerTTCSN complex controls the stability of selected synaptic proteins via a torsinA-dependent processEMBO J201130118119321102408
- AlmasyLBressmanSBRaymondDIdiopathic torsion dystonia linked to chromosome 8 in two Mennonite familiesAnn Neurol19974246706739382482
- BlanchardAEaVRoubertieADYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 geneHum Mutat201132111213122421793105
- FuchsTGavariniSSaunders-PullmanRMutations in the THAP1 gene are responsible for DYT6 primary torsion dystoniaNat Genet200941328628819182804
- GavariniSCayrolCFuchsTDirect interaction between causative genes of DYT1 and DYT6 primary dystoniaAnn Neurol201068454955320865765
- MazarsRGonzalez-de-PeredoACayrolCThe THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: A link between DYT6 and DYT3 dystoniasJ Biol Chem201028518133641337120200153
- BentivoglioARIalongoTContarinoMFValenteEMAlbaneseAPhenotypic characterization of DYT13 primary torsion dystoniaMov Disord200419220020614978677
- Gimenez-RoldanSDelgadoGMarinMVillanuevaJAMateoDHereditary torsion dystonia in gypsiesAdv Neurol19885073813400517
- ChoueryEKfouryJDelagueVA novel locus for autosomal recessive primary torsion dystonia (DYT17) maps to 20p11.22-q13.12Neurogenetics20089428729318688663
- NygaardTGMarsdenCDDuvoisinRCDopa-responsive dystoniaAdv Neurol1988503773843041760
- NygaardTGSnowBJFahnSCalneDBDopa-responsive dystonia: clinical characteristics and definitionSegawaMHereditary Responsive Dystonia with Marked Diurnal FluctuationNew York, NYThe Partenon Publ Group Lanc19932135
- RondotPAicardiJGoutieresFZieglerMDopa-sensitive dystoniaRev Neurol (Paris)1992148116806861303557
- NygaardTGDopa-responsive dystonia. delineation of the clinical syndrome and clues to pathogenesisAdv Neurol1993605775858420194
- de YebenesJGMoskowitzCFahnSSaint HilaireMHLong-term treatment with levodopa in a family with autosomal dominant torsion dystoniaAdv Neurol1988501011113400489
- ClotFGrabliDCazeneuveCExhaustive analysis of BH4 and dopamine biosynthesis genes in patients with dopa-responsive dystoniaBrain20091321753176319491146
- GaravagliaBInvernizziFCarboneMLGTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: Identification and functional characterization of four novel mutationsJ Inherit Metab Dis200427445546315303002
- AsmusFGasserTDystonia-plus syndromesEur J Neurol201017Suppl 1374520590807
- KurianMALiYZhenJClinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: An observational cohort and experimental studyLancet Neurol2011101546221112253
- Tezenas du MontcelSClotFVidailhetMEpsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromesJ Med Genet200643539440016227522
- KoukouniVValenteEMCordivariCBhatiaKPQuinnNPUnusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer’s crampMov Disord200823131913191518702114
- NardocciNZorziGBarzaghiCMyoclonus-dystonia syndrome: Clinical presentation, disease course, and genetic features in 11 familiesMov Disord2008231283417853490
- RaymondDSaunders-PullmanRde Carvalho AguiarPPhenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutationsMov Disord200823458859218175340
- RozeEBetuingSDeytsCVidailhetMCabocheJPathophysiology of Huntington’s disease: An updateRev Neurol (Paris)20081641297799418808762
- AsmusFZimprichATezenas Du MontcelSMyoclonus-dystonia syndrome: Epsilon-sarcoglycan mutations and phenotypeAnn Neurol200252448949212325078
- DohenyDDanisiFSmithCClinical findings of a myoclonus-dystonia family with two distinct mutationsNeurology20025981244124612391355
- ValenteEMEdwardsMJMirPThe epsilon-sarcoglycan gene in myoclonic syndromesNeurology200564473773915728306
- MarechalLRauxGDumanchinCSevere myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutationAm J Med Genet B Neuropsychiatr Genet2003119B111411712707948
- MisbahuddinAPlaczekMLennoxGTaanmanJWWarnerTTMyoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan geneMov Disord20072281173117517230465
- GerritsMCFonckeEMde HaanRPhenotype-genotype correlation in Dutch patients with myoclonus-dystoniaNeurology200666575976116534121
- KinugawaKVidailhetMClotFApartisEGrabliDRozeEMyoclonus-dystonia: An updateMov Disord200924447948919117361
- GrabowskiMZimprichALorenz-DepiereuxBThe epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprintedEur J Hum Genet200311213814412634861
- DobynsWBOzeliusLJKramerPLRapid-onset dystonia-parkinsonismNeurology19934312259626028255463
- BrashearADobynsWBde Carvalho AguiarPThe phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 geneBrain2007130Pt 382883517282997
- de Carvalho AguiarPSweadnerKJPennistonJTMutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonismNeuron200443216917515260953
- PostBOzeliusLJTijssenMAJJuvenile rapid-onset dystonia parkinsonism due to a ‘de novo’ mutation in the ATP1A3 geneJ Pediatr Neurol200972171173
- BrashearAButlerIJHylandKFarlowMRDobynsWBCerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonismAnn Neurol19984345215269546335
- CamargosSScholzSSimon-SanchezJDYT16, a novel young-onset dystonia-parkinsonism disorder: Identification of a segregating mutation in the stress-response protein PRKRALancet Neurol20087320721518243799
- MohrJMageroyKSex-linked deafness of a possibly new typeActa Genet Stat Med196010546213771732
- TranebjaergLSchwartzCEriksenHA new X linked recessive deafness syndrome with blindness, dystonia, fractures and mental deficiency is linked to Xq22J Med Genet1995322572637643352
- KreiselSHBinderJWöhrleJCDystonia in the Mohr-Tranegjaerg syndrome responds to GABAergic substancesMov Disord2004191241124315390009
- UjikeHTanabeYTakehisaYHayabaraTKurodaSA family with X-linked dystonia-deafness syndrome with a novel mutation in the DDP geneArch Neurol2001581004100711405816
- AguirreLAPérez-BasMVillamarMA Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexesNeuromuscul Disord2008181297998118952432
- JinHMayMTranebjaergLA novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindnessNat Genet1996141771898841189
- KoehlerCMLeuenbergerDMerchantSHuman deafness dystonia syndrome is a mitochondrial diseaseProc Natl Acad Sci U S A1999962141214610051608
- EzquerraMCampdelacreuJMuñozETolosaEMartíMJA novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndromeArch Neurol20056230630815710860
- SwerdlowRHWootenGFA novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndromeAnn Neurol20015053754011601506
- WillemseJBenign idiopathic dystonia in the first year of lifeDev Med Child Neurol1986283553632873071
- Fernández-AlvarezETransient movement disorders in childrenJ Neurol1998245159457621
- DeonnaTZieglerALNielsenJTransient idiopathic dystonia in infancyNeuropediatrics1991222202241775219
- AngeliniLRumiVLampertiENardocci N Transient paroxysmal dystonia in infancyNeuropediatrics1988191711743205373
- ZorziGContiCErbaAGranataTAngeliniLNardocciNParoxysmal dyskinesias in childhoodPediatr Neurol200328316817212770667
- DemirkiranMJankovicJParoxysmal dyskinesias: Clinical features and classificationAnn Neurol19953845715797574453
- BressmanSBFahnSBurkeREParoxysmal non-kinesigenic dystoniaAdv Neurol1988504034133400499
- AuburgerGRatzlaffTLunkesAA gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197Genomics199631190948808284
- BhatiaKPSolandVLBhattMHQuinnNPMarsdenCDParoxysmal exercise-induced dystonia: Eight new sporadic cases and a review of the literatureMov Disord1997126100710129399228
- SulsADedekenPGoffinKParoxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1Brain20081311831184418577546
- WeberYGStorchAWuttkeTVGLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakJ Clin Invest200811862157216818451999
- ZorziGCastellottiBZibordiFGelleraCNardocciNParoxysmal movement disorders in GLUT1 deficiency syndromeNeurology200871214614818606970
- FinkJKHederaPMathayJGAlbinRLParoxysmal dystonic choreoathetosis linked to chromosome 2q: Clinical analysis and proposed pathophysiologyNeurology19974911771839222187
- BennettLBRoachESBowcockAMA locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16Neurology200054112513010636137
- WangJLCaoLLiXHIdentification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesiasBrain201113434903498
- LeeHYHuangYBruneauNMutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsionsCell Rep2012121222832103
- NardocciNZorziGGrisoliMAcquired hemidystonia in childhood: a clinical and neuroradiologic study of 13 patientsPediatr Neurol1996151081138888043
- ChuangCFahnSFruchtSJThe natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literatureJ Neurol Neurosurg Psychiatry200272596711784827
- MarksWAHoneycuttJAcostaFReedMDeep brain stimulation for pediatric movement disordersSemin Pediatr Neurol200916909819501337
- GoodmanSIMarkeySPMoePGMilesBSTengCCGlutaric aciduria; a “new” disorder of amino acid metabolismBiochem Med19751212211137568
- BieryBJSteinDEMortonDHGoodmanSIGene structure and mutations of Glutaryl-Coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the AmishAm J Hum Genet199659100610118900227
- KolkerSKoellerDMOkunJGHoffmannGFPathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiencyAnn Neurol20045571214705106
- LindnerMKolkerSSchulzeAChristensenEGreenbergCRHoffmannGFNeonatal screening for glutaryl-CoA dehydrogenase deficiencyJ Inherit Metab Dis20042785185915505392
- IafollaAKKahlerSGMegaloencephaly in the neonatal period as the initial manifestation of glutaric aciduria type IJ Pediatr1989114100410062627209
- HoffmannGFAthanassopoulosSBurlinaABClinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiencyNeuropediatrics1996271151238837070
- BusquetsCMerineroBChristensenEGlutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically, and biochemically distinctPediatr Res20004831532210960496
- Fernández-ÁlvarezEGarcía-CazorlaASansAHand tremor and orofacial dyskinesia: clinical manifestations of glutaric aciduria type I in a young girlMov Disord20031810761079
- BahrOMaderIZschockeJDichgansJSchulzJBAdult onset glutaric aciduria type I presenting with leukoencephalopathyNeurology2002591802180412473778
- KulkensSHartingISauerSLate-onset neurologic disease in glutaryl-CoA dehydrogenase deficiencyNeurology2005642142214415985591
- GitiuaxCRozeEKinugawaKSpectrum of movement disorders associated with glutaric aciduria type I. A study of 16 patientsMov Disord2008232392239718823014
- HoffmannGFAthanassopoulosSBurlinaABClinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiencyNeuropediatrics1996271151238837070
- LeschMNyhanWLA familial disorder of uric acid metabolism and central nervous system functionAm J Med19643656157014142409
- JinnahHADe GregorioLHarrisJCThe spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported casesMutat Res200046330932611018746
- KelleyWNRosenbloomFMHendersonJFSeegmillerJEA specific enzyme defect in gout associated with overproduction of uric acidProc Natl Acad Sci U S A19676717351739
- JinnahHALewisRFVisserJEOcular motor dysfunction in Lesch-Nyhan diseasePediatr Neurol20012420020411301220
- MizunoTLong-term follow-up of ten patients with Lesch-Nyhan syndromeNeuropediatrics1986171581613762872
- LynchBJNoetzelMJRecurrent coma and Lesch-Nyhan syndromePediatr Neurol199173893911764145
- SaitoYTakashimaSNeurotransmitter changes in the pathophysiology of Lesch-Nyhan syndromeBrain Dev200022S122S13110984673
- WongDFHarrisJCNaiduSDopamine transporters are markedly reduced in Lesch-Nyhan disease in vivoProc Natl Acad Sci U S A199693553955438643611
- BerardelliAThompsonPDZaccagniniATwo sisters with generalized dystonia associated with homocystinuriaMov Disord199161631652057008
- BurlinaAPEdiniCBurlinaABTreatment of extrapyramidal symptoms in a patient with homozigous homocystinuriaJ Inherit Metab Dis20022513513612118530
- GibsonJBCarsonNAJNeillDWPathological findings in homocystinuriaJ Clin Pathol19641742743714195630
- KemspterPAKBrentonDPGaleANMSternGMDystonia in homocystinuriaJ Neurol Neurosurg Psychiatry1988518598623404194
- SeowHFBroerSBroerAHartnup disorder is caused by mutations in the gene encoding the neutral aminoacid transporter SLC6A19Nat Genet2004361003100715286788
- DarrasBTAmpolaMGDietzWHGilmoreHEIntermittent dystonia in Hatnup diseasePediatr Neurol198951181202712944
- SturleySLPattersonMCBalchWLiscumLThe pathophysiology and mechanisms of NP-C diseaseBiochim Biophys Acta20041685838715465429
- VanierMTMillatGNiemann-Pick disease type CClin Genet20036426928112974729
- ChikhKVeySSimonotCVanierMTMillatGNiemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 proteinMol Genet Metab20048322023015542393
- UcEYWengerDAJankovicJNiemann-Pick disease type C: two cases and an updateMov Disord2000151199120311104205
- PattersonMCVecchioDPradyHMiglustat for treatment of Niemann-Pick C disease: a randomised control studyLancet Neurol2007676577217689147
- FriedeRLInfantile bilateral striatal necrosisGoodmanSINorenbergMDShikesRHDevelopmental NeuropathologyWien, AustriaSpringer19758889
- GoutièresFAicardiJAcute neurological dysfunction associated with destructive lesions of the basal ganglia in childrenAnn Neurol1982123283327149658
- LeuzziVFavatàISeriSBilateral striatal lesionsDev Med Child Neurol19883022522573290014
- CampistolJCusiVVernetAFernandez-AlvarezEDystonia as a presenting sign of subacute necrotizing encephalomyelopathy in infancyEur J Pediatr19861445895913709574
- YamamotoKChibaHIshitobiMNakagawaHOgawaTIshiiKAcute encephalopathy with bilateral striatal necrosis: favourable response to corticosteroid therapyEur J Paediatr Neurol19971414510728192
- BrandelJ-PVidailhetMNosedaGHarpeyJ-PAgidYMycoplasma pneurmoniae postinfectious encephalomyelitis with bilateral striatal necrosisMov Disord1996113333358723156
- FujitaKTakeuchiYNishimuraATakadaHSawadaTSerial MRI in infantile bilateral striatal necrosisPediatr Neurol1994101571608024666
- CraverRDDuncanMCNelsonJSFamilial dystonia and choreoathetosis in three generations associated with bilateral striatal necrosisJ Child Neurol1996111851888734018
- DaleRCChurchAJBentonSPost-streptococcal autoimmune dystonia with isolated bilateral striatal necrosisDev Med Child Neurol20024448548912162386
- MizuguchIMAcute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and TaiwanBrain Dev19971981929105653
- CampistolJGassioRPinedaMFernandez-AlvarezEAcute necrotizing encephalopathy of childhood (infantile thalamic necrosis): two non-Japanese casesDev Med Child Neurol1998407717749881807
- YoshikawaHWatanabeTAbeTOdaYClinical diversity in acute necrotizing encephalopathyJ Child Neurol19991424925510334400
- FujimotoYShibataMTsuyukiMOkadaMTsuzukiKInfluenza A virus encephalopathy with symmetrical thalamic lesionsEur J Pediatr200015931932110834515
- VoudrisKASkaardoutsouAHaronitisJVagiakouEAZeisPMBrain MRI findings in influenza A-associated acute necrotizing encephalopathy of childhoodEur J Paediatr Neurol2001519920211585108
- RavidSTopperLEviatarLAcute necrotizing encephalopahy presenting as a basal ganglia syndromeJ Child Neurol20011646146211417619
- ZengWQAl-YamaniEAciernoJSJrBiotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3Am J Hum Genet200577162615871139
- OzandPTGasconGGAl EssaMBiotin-responsive basal ganglia disease: a novel entityBrain1998121126712799679779
- DebsRDepienneCRastetterABiotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutationsArch Neurol20106712613020065143
- AicardiJAicardi-Goutières syndrome: special type early-onset encephalopathyEur J Paediatr Neurol20026Suppl AA1A712365357
- MikatiMAKramerUZupancMLShanahanRJAlternating hemiplegia of childhood: clinical manifestations and long-term outcomePediatr Neurol20002313414111020638
- CasaerPFlunarizine in alternating hemiplegia in childhood. An international study of 12 childrenNeuropediatrics1987181911953320807
- KarthaNTherapeutic challenges in dystoniaNeurol Clin201028492794020816271
- BalashYGiladiNEfficacy of pharmacological treatment of dystonia: Evidence-based review including meta-analysis of the effect of botulinum toxin and other cure optionsEur J Neurol200411636137015171731
- AlbaneseAAsmusFBhatiaKPEFNS guidelines on diagnosis and treatment of primary dystoniasEur J Neurol201118151820482602
- BurlinaAPZaraGHoffmannGFZschockeJBurlinaABManagement of movement disorders in glutaryl-CoA dehydrogenase deficiency: Anticholinergic drugs and botulinum toxin as additional therapeutic optionsJ Inherit Metab Dis200427691191515505399
- SangerTDKukkeSNSherman-LevineSBotulinum toxin type B improves the speed of reaching in children with cerebral palsy and arm dystonia: An open-label, dose-escalation pilot studyJ Child Neurol200722111612217608320
- NarayanRKLoubserPGJankovicJDonovanWHBontkeCFIntrathecal baclofen for intractable axial dystoniaNeurology1991417114111422067645
- AlbrightALFersonSSIntrathecal baclofen therapy in childrenNeurosurg Focus2006212e3
- BardutzkyJTronnierVSchwabSMeinckHMIntrathecal baclofen for stiff-person syndrome: Life-threatening intermittent catheter leakageNeurology200360121976197812821743
- HouJGOndoWJankovicJIntrathecal baclofen for dystoniaMov Disord200116612011202
- AltermanRLSnyderBJDeep brain stimulation for torsion dystoniaActa Neurochir Suppl200797Pt 219119917691304
- IsaiasIUAltermanRLTagliatiMOutcome predictors of pallidal stimulation in patients with primary dystonia: The role of disease durationBrain20081311895190218567622
- CoubesPRoubertieAVayssiereNHemmSEchenneBTreatment of DYT1-generalised dystonia by stimulation of the internal globus pallidusLancet200035592222220222110881900
- ZorziGMarrasCNardocciNStimulation of the globus pallidus internus for childhood-onset dystoniaMov Disord20052091194120015895426
- GruberDKuhnAASchoeneckerTPallidal and thalamic deep brain stimulation in myoclonus-dystoniaMov Disord201025111733174320623686
- SpeelmanJDContarinoMFSchuurmanPRTijssenMAde BieRMDeep brain stimulation for dystonia: Patient selection and outcomesEur J Neurol201017Suppl 110210620590816
- TimmermannLPaulsKAWielandKDystonia in neurodegeneration with brain iron accumulation: Outcome of bilateral pallidal stimulationBrain201013370171220207700